XML 32 R20.htm IDEA: XBRL DOCUMENT
v3.20.4

STOCK-BASED COMPENSATION | 9 Months Ended
--- | ---
Dec. 31, 2020
Share-based Payment Arrangement [Abstract] |
Share-based Payment Arrangement [Text Block] | NOTE 15 – STOCK-BASED COMPENSATION As of December 31, 2020, under both the Company’s previous 2008 and current 2018 Omnibus Incentive Plans, a total of 8,327,627 shares of common stock have been issued to employees and advisors. In addition, 1.8 million restricted share units fair valued at $771 thousand with a weighted average value of $0.42 per share, have been granted but not yet issued from different Incentive Plans and Grants. Additionally, options held by advisors to purchase 210,000 shares of common stock fair valued at $96 thousand with a weighted average of $0.46 per share, that have been granted but are to be issued over a vesting period, between Fiscal 2023 and Fiscal 2024. Options granted and issued before the vesting period are expensed when issued. The options are fair valued using a Black-Scholes Pricing Model with the following assumptions:
|  | Granted in Fiscal 2021 |  |  | Granted in Fiscal 2020 |
Expected life of options |  | 5 years |  |  | 5 years |
Vested options |  |  | 100 | % |  |  | 100 | %
Risk free interest rate |  |  | 0.68 | % |  |  | 2.57 | %
Expected volatility |  |  | 249 | % |  |  | 249 | %
Expected dividend yield |  | Nil |  |  | Nil |
The expense associated with share-based payments to employees, directors, advisors, and contractors is allocated over the vesting or service period and recognized in the Selling, general and administrative expenses (including research and development). For the nine months ended December 31, 2020, the Company’s share-based expense and option-based expense shown in Selling, general and administrative expenses (including research and development) was $459 thousand and $64 thousand, respectively. The expense associated with share-based payments to employees, directors, advisors and contractors is allocated over the vesting or service period and recognized in the Common Stock and Additional Paid in Capital. For the nine months ended December 31, 2019, the Company’s share-based expense and option-based expense shown in Selling, general and administrative expenses (including research and development) was $525 thousand and $17 thousand respectively.
Non-vested shares |  | Shares (in thousands) (#) |  |  | Weighted average grant date fair value ($) |
Non-vested shares as of March 31, 2020 |  |  | 1,851 |  |  |  | 0.40 |
Granted |  |  | 45 |  |  |  | 1.04 |
Vested |  |  | (70 | ) |  |  | 0.45 |
Cancelled/Forfeited |  |  | - |  |  |  | - |
Non-vested shares as of December 31, 2020 |  |  | 1,826 |  |  |  | 0.42 |
Options |  | Shares (in thousands) (#) |  |  | Weighted average grant date fair value ($) |  |  | Weighted average exercise price ($) |
Options outstanding as of March 31, 2020 |  |  | 160 |  |  |  | 0.40 |  |  |  | 0.39 |
Granted |  |  | 150 |  |  |  | 0.64 |  |  |  | 0.30 |
Exercised |  |  | (100 | ) |  |  | 0.64 |  |  |  | 0.30 |
Cancelled/Forfeited |  |  | - |  |  |  | - |  |  |  | - |
Options outstanding as of December 31, 2020 |  |  | 210 |  |  |  | 0.46 |  |  |  | 0.36 |
There was a combined unrecognized expense of $277 thousand related to non-vested shares and share options that the Company expects to be recognized over weighted average life of 0.65 years.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration